Filing Details
- Accession Number:
- 0001001250-12-000090
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-08-28 17:11:01
- Reporting Period:
- 2012-08-24
- Filing Date:
- 2012-08-28
- Accepted Time:
- 2012-08-28 16:11:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1001250 | Estee Lauder Companies Inc | EL | Perfumes, Cosmetics & Other Toilet Preparations (2844) | 112408943 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
942617 | S Ronald Lauder | C/O The Estee Lauder Companies Inc. 767 Fifth Avenue New York NY 10153 | Chairman, Clinique Labs, Llc | No | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Disposition | 2012-08-24 | 211,747 | $59.83 | 1,283,151 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2012-08-24 | 133,253 | $60.15 | 1,149,898 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2012-08-27 | 356,460 | $59.97 | 793,438 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Class A Common Stock | 1,494,898 | Direct | |
Class A Common Stock | 6,364 | Indirect | By Decendants of RSL 1966 Trust |
Footnotes
- The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. RSL undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by such reporting person at each separate price within the range.
- Sales prices in the range from $59.05 to $60.04 per share, inclusive.
- Sales prices in the range from $60.05 to $60.35 per share, inclusive.
- Sales prices in the range from $59.75 to $60.42 per share, inclusive.
- RSL disclaims beneficial ownership of these shares to the extent he does not have a pecuniary interest in such securities.